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Aims: This study was conducted to assess the isolated and combined effects of nandrolone and resistance
training on cardiac morphology, function, andmRNA expression of pathological cardiac hypertrophymarkers.
Main methods: Wistar rats were randomly divided into four groups and submitted to 6 weeks of treatment
with nandrolone and/or resistance training. Cardiac parameters were determined by echocardiography. Heart
was analyzed for collagen inﬁltration. Real-time RT-PCR was used to assess the pathological cardiac
hypertrophy markers.
Key ﬁndings: Both resistance training and nandrolone induced cardiac hypertrophy. Nandrolone increased the
cardiac collagen content, and reduced the cardiac index in non-trained and trained groups, when comparedwith
the respective vehicle-treated groups. Nandrolone reduced the ratio of maximum early to late transmitral ﬂow
velocity in non-trained and trained groups, when compared with the respective vehicle-treated groups.
Nandrolone reduced the alpha-myosin heavy chain gene expression in both non-trained and trained groups,
when comparedwith the respective vehicle-treated groups. Training reduced the beta-myosin heavy chain gene
expression in the groups treated with vehicle and nandrolone. Only the association between training and
nandrolone increased the expression of the skeletal alpha-actin gene and atrial natriuretic peptide in the left
ventricle.
Signiﬁcance: This study indicated that nandrolone, whether associated with resistance training or not, induces
cardiac hypertrophy, which is associatedwith enhanced collagen content, re-expression of fetal genes the in left
ventricle, and impaired diastolic and systolic function.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Anabolic androgenic steroids (AAS) comprise a group of drugs
commonly used among athletes, frequently in combination with
resistance training (Kuhn, 2002). Although the increase in muscle
mass andpower inducedbyAAS (Bhasin et al., 1996) is still questionable
(ParkinsonandEvans, 2006), it hasbeenwell established thatAASabuseias Fisiológicas, Faculdade de
Campinas, FOP/UNICAMP, Av.
5 19 2106 5380; fax: +55 19
des).
.
evier OA license.is associatedwith detrimental side effects (Sullivan et al., 1998). Several
researchers have observed that AAS may induce pathological left
ventricular hypertrophy (Pärssinen et al., 2000a; Nottin et al., 2006),
with disproportionate extracellular collagen accumulation and intersti-
tial ﬁbrosis (Nieminen et al., 1996; Palatini et al., 1996; Rocha et al.,
2007). On the other hand, some reports have shown no differences in
left ventricular morphofunction between AAS users and non-users
(Thompson et al., 1992; Pärssinen et al., 2000b). These conﬂicting data
may be related to the difﬁculty of ﬁnding athletes who admit the exact
pattern of AAS administration.Moreover, not only the type and regimen
of AAS administration, but the additional inﬂuence of dietary intake and
patterns and/or training intensity may have different effects on
individual subjects (Parkinson and Evans, 2006). Although there have
been conﬂicting results and uncertainty as regards the underlying
632 A.P. Tanno et al. / Life Sciences 89 (2011) 631–637mechanisms of AAS-induced left ventricular hypertrophy, it is known
that inappropriate increase in left ventricular mass itself may compro-
mise cardiac function (Collins et al., 2001).
In this context, animal models are very useful when the aim of the
study is to evaluate cause-and-effect relationships, such as the effect
of a speciﬁc type or dose of AAS on the heart, for example. One of the
major advantages of using animal models is the ability to have precise
control of environmental variables, quality and pattern of food intake,
as well as AAS administration regimen and dosages.
Considering that many young people, who practice intense physical
exercises, particularly resistance training performed in a vigorous
manner, frequently consume high doses of AAS, usually in complete
disregard for the guidance provided by their physical educators, it
would be interesting to evaluate the effect of the association of AAS and
intense physical exercise.
Resistance training by weight lifting in water (Cunha et al., 2005a,b)
is an experimental protocol thatmimics this reality. Itwas observed that
subsensitivity to phenylephrine induced by this protocol in the rat
thoracic aorta was blocked by nandrolone decanoate. It was suggested
that AAS seemed to damage endothelial function by increasing low
density cholesterol levels (Cunha et al., 2005a). In order to evaluate the
cardiovascular effects of AAS, itwould also be interesting to evaluate the
cardiac effects of nandrolone administration and resistance training in
the same experimental protocol.
Therefore, the aim of this study was to investigate under highly
controlled conditions the isolated and combined effects of high-dose
nandrolone administration and resistance training on cardiac function,
and the mechanisms underlying the functional adaptations. For this
purpose,we evaluated the left ventricularmorphology and function and
the expression of pathological cardiac hypertrophy markers.
Materials and methods
General procedures
Two-month-old male Wistar rats (CEMIB/UNICAMP, Campinas,
SP), were housed in a temperature-controlled room (22±2 °C) with
lights on from 6 a.m. to 6 p.m., and received commercial rodent chow
(Moinho Primor®) and ﬁltered water ad libitum. The rats were
randomized into four groups: Non-trained+Vehicle (NTV) or
Nandrolone (NTN), Trained+vehicle (TV) or nandrolone (TN). An
intramuscular injection of either vehicle (0.2 mL/kg) or nandrolone
(5 mg/kg) was administered to Vehicle-treated (vehicle=propylene
glycol) or Nandrolone Decanoate-treated rats (Deca-Durabolin®,
Organon, São Paulo, Brazil), twice a week, for 6 weeks. The dose of
nandrolone is comparable with that frequently used by athletes in
doping processes (600 mg/week or approximately 8 mg/kg/week)
(Pope and Katz, 1988; Norton et al., 2000). All procedures were
performed in compliance with The Guide for the Care and Use of
Laboratory Animals published by the US National Institute of Health
(NIH Publication No. 85-23, revised 1996), and the Institutional
Committee for Ethics in Animal Research approved all experiments
(Protocol Number 944-1).
Training protocol
The training protocolwas conducted as previously described (Cunha
et al., 2005a, b). Brieﬂy, during the ﬁrst (pre-training) week, trained
animals were adapted to water. Adaptation consisted of sessions of
weight lifting (once a day for ﬁve days) in water at 30 °C±2 °C with an
incremental number of sets (two to four) and repetitions (ﬁve to ten),
30 s rest between each set, carrying a load of 50% body weight strapped
to the chest. On the last day of the adaptation period, animals were
performing four sets of ten repetitions (lifts). Subsequently, trained rats
were submitted to a high-intensity exercise training for 5 weeks. During
theﬁrst 2 weeks of training, animals performed 4 sets of 10 jumps (lifts)per set carrying a load of 50% body weight strapped to the chest, with
30 s rest between each set. In the third and fourth training weeks,
animals performed the same exercise carrying a load of 60% body
weight, and in the last week, this loadwas adjusted to 70% bodyweight.
Echocardiography studies
Echocardiographic features were obtained using the recommen-
dations of the American Society of Echocardiography. The examswere
performed in anesthetized rats (ketamine, 50 mg/kg, xylazine 10 mg/
kg, i.p), 48 h after the last exercise session. All the transthoracic
echocardiograms were performed by a single, blinded observer with
the use of a Sequoia 512 (ACUSON Corporation, Mountain View, CA)
appliance, which offers a 10- to 14-MHz multifrequential linear
transducer, as described in detail elsewhere (Santos et al., 2006).
Collagen content
Other animals, submitted to the same treatment, were sacriﬁced by
decapitation and the heart was removed from the thoracic cavity,
trimmed of excess non-cardiac tissue and weighed. The left ventricle
was dissected, weighed, sliced into three sections perpendicular to the
long axis and ﬁxed in 10% neutral buffered formalin for 24 h. After
embedding the material in parafﬁn, 6 μm sections were taken from the
midventricular level and stained with Picrosirius Red, which allows the
collagenmolecules to be studied (Junqueira et al., 1979; Montes, 1996).
Slides were analyzed in an Axioscope (Zeiss, Oberkochen, DE), using
KS400 image analysis software.
Testosterone
Blood was collected from the trunk in a heparin-coated tube,
centrifuged (700 g for 20 min at 4 °C), and plasma was frozen and
stored at −20 °C for total testosterone quantiﬁcation as previously
described (Castor et al., 2009).
Cardiac hypertrophy markers
Other animals, submitted to the same treatment, were sacriﬁced
by decapitation and the heart was removed from the thoracic cavity.
The relative messenger ribonucleic acid (mRNA) levels of Atrial
Natriuretic Peptide (ANP), skeletal α-actin, alfa-Myosin Heavy Chain
(α-MHC) and beta-Myosin Heavy Chain (β-MHC) in the left ventricle
were analyzed by Real-Time Polymerase Chain Reaction (Real-time
RT-PCR).
Frozen tissue samples (100 mg) were homogenized in Trizol and
ribonucleic acid (RNA) was isolated according to the manufacturer's
instructions (Invitrogen Life Technologies). RNA concentration was
determined by spectrophotometric measurement of the absorbance at
260 nm and checked for integrity by EtBr-agarose gel electrophoresis.
RNA was primed with 0.5 μg/μl oligo dT (12–18) to generate the ﬁrst
strand desoxyribonucleic acid (DNA). Reverse transcription (RT) was
performed using SuperScript™ II Reverse Transcriptase.
Before the samples were analyzed, a standard curve for each
amplicon was obtained using serial dilutions of cDNA to determine
ampliﬁcation primer efﬁciency and the amount of material for each
reaction. Primers were designed using Primer 3 software (http://frodo.
wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). A DNA sequence was
obtained from GenBank and primers were made for separate exons to
distinguish the PCR products derived from cDNA from those derived
from genomic DNA contaminants by their size. ThemRNA expression of
pathological left ventricle hypertrophy markers was assessed by
oligonucleotide primers as follows: for α-MHC (sense: 5′-CGA GTC
CCA GGT CAA CAA G-3′, antisense: 5′-AGG CTC TTT CTG CTG GAC C-3′);
for β-MHC (sense: 5′-CAT CCC CAA TGA GAC GAA G-3′, antisense: 5′-
AGG CTC TTT CTG CTG GAC A-3′); for ANP (sense: 5′-CTT CGG GGG TAG
633A.P. Tanno et al. / Life Sciences 89 (2011) 631–637GAT TGA C-3′, antisense: 5′-CTT GGG ATC TTT TGC GAT CT-3′); for
Skeletal α-actin (sense: 5′-ACC ACA GGC ATT GTT CTG GA-3′, antisense:
5′-TAA GGT AGT CAG TGA GGT CC-3′). Real-time quantiﬁcation of the
target geneswas performedwith a SYBRGreen PCRMasterMix, (Applied
Biosystem, PE) using the ABI PRISM 7700 Sequence Detection System.
The expression of cyclophilin (sense: 5′-AAT GCT GGA CCA AAC ACA
AA-3′, antisense: 5′-CCT TCT TTC ACC TTC CCA AA-3′) was measured as
an internal control for sample variation in RT reaction. An aliquot of the
RT reaction was used for 50 cycle PCR ampliﬁcation in the presence of
SYBR green ﬂuorescent dye according to a protocol provided by the
manufacturer. Relative quantities of target gene expression were
compared after normalization to the values of cyclophilin (ΔCT). Fold
change inmRNA expressionwas calculated using the differences inΔCT
values between the two samples (ΔΔCT) and equation 2−ΔΔCT. Results
were expressed as % of control.
Statistical analysis
Results are expressed as means±SEM. Data were compared using
two-way analysis of variance (ANOVA) followed by the Tukey test.
Differences were considered statistically signiﬁcant when pb0.05.
Results
Body weight and testosterone levels
When the protocol ended, the trained animals treated with either
vehicle (TV: 337±11 g) or nandrolone (TN: 298±10 g) presented
lower body weight than the non-trained rats (NTV: 374±12 and
NTN: 333±5 g; pb0.05). Furthermore, both NTN and TN groups
presented lower body weight than the respective NTV and TV groups
at the end of the experimental protocol (pb0.05). Testosterone was
signiﬁcantly diminished in the NTN (55.95±11.40 ng/dL) and TN
(42.39±6.81 ng/dL) groups, compared with the NTV (157.10±
18.40 ng/dL) and TV (104.50±26.46 ng/dL) groups, respectively
(pb0.05).
Left ventricular morphology
No signiﬁcant differences in left ventricle mass (LVMe) evaluated
by echocardiography, or by wet left ventricle weight (Wet LV weight)
were observed among the groups (Table 1; pN0.05). However, LVMe
corrected by body weight (LVMe/BW), and Wet LV weight correctedTable 1
Cardiac parameters determined by the echocardiographic system in rats submitted to resis
Parameters NTV TV
Wet LV weight (g) 0.66±0.01 0
LVMe (g) 0.65±0.02 0
Wet LV weight(g)/BW (kg) 1.78±0.06a 1
LVMe (g)/BW (kg) 1.71±0.07a 1
RWT (mm) 0.38±0.01a 0
IVSDia (mm) 0.38±0.02a 0
CI (mL/min/g) 213.5±11a 20
HR (bpm) 219±6.2
FS (%) 0.42±0.01 0
E-wave (cm/s) 0.54±0.03a 0
A-wave (cm/s) 0.27±0.02a 0
E/A ratio 1.91±0.10a 1
IVRTcor 1.80±0.02a 1
NTV = Non-trained+vehicle; NTN = Non-trained+nandrolone; TV = Trained+vehicle;
ventricle mass; Wet LV/BW = Wet left ventricle weight corrected by body weight; LVMe/
IVSDia= Interventricular septum in the end-diastole; CI = Cardiac index; HR = Heart rate;
transmitral ﬂow velocity; E/A ratio = Ratio of maximum early to late transmitral ﬂow velo
indicate statistically different groups (Two-way ANOVA+Tukey test; pb0.05). N=8 animaby body weight (Wet LV weight/BW) were found to be signiﬁcantly
higher in the trained groups, whether treated with nandrolone or not,
when compared with the respective non-trained groups (Table 1;
pb0.05). In the NTN group, nandrolone promoted higher LVMe/BW,
and higher Wet LV weight/BW, in comparison with the NTV group
(Table 1; pb0.05). Relative left ventricle wall thickness (RWT) was
increased in response to high-intensity physical training in rats
treated with vehicle or nandrolone, when compared with the
respective non-trained groups (Table 1; pb0.05). Moreover, the
NTN group also presented higher RWT in comparison with the NTV
group (Table 1; pb0.05). The interventricular septum thickness in the
end-diastole (IVSDia) was increased in both the NTN and TV groups,
when compared with the NTV group. The association between
nandrolone and training potentiated the increase in IVSDia in
comparison with all groups (Table 1; pb0.05).Systolic function
Nandrolone treatment reduced the cardiac output/bodyweight ratio
(cardiac index), in non-trained and trained groups, when compared
with the respective vehicle-treated groups (Table 1; pb0.05). Therewas
no difference in left ventricular fractional shortening or in heart rate
among the groups (Table 1; pN0.05).Diastolic function
Nandrolone treatment reduced early transmitral ﬂow velocity
(E-wave) in both non-trained and trained groups, when compared
with the respective vehicle-treated groups (Table 1; pb0.05). Late
transmitral ﬂow velocity (A-wave) was signiﬁcantly higher in the TV
and TN groups, compared with the NTV and NTN groups, respectively
(Table 1; pb0.05). The NTN group also presented a higher A-wave,
when compared with the NTV group (Table 1; pb0.05). Ratio of
maximum early to late transmitral ﬂow velocity (E/A ratio) was
signiﬁcantly lower in the trained groups, whether they were treated
with nandrolone or not, respectively, when compared with the non-
trained groups (Table 1; pb0.05). Nandrolone treatment induced a
decrease in the E/A ratio both in theNTN and TNgroups, comparedwith
the respective NTV and TV groups (Table 1; pb0.05). Isovolumic
relaxation time corrected by the square root of the RR interval was
increased in theNTNandTNgroupswhencomparedwith the respective
NTV and TV Groups (Table 1; pb0.05).tance training and treatment with nandrolone or vehicle.
NTN TN
.66±0.01 0.69±0.02 0.67±0.01
.66±0.03 0.67±0.02 0.67±0.04
.98±0.06b 2.07±0.05b 2.27±0.05c
.95±0.13b 1.92±0.06b 2.24±0.09c
.46±0.01b 0.51±0.02b 0.56±0.02c
.45±0.01b 0.48±0.01b 0.56±0.03c
4.3±19a 184.1±18b 150.6±14b
224±12.4 251±14.3 257±36.0
.43±0.02 0.45±0.02 0.47±0.03
.51±0.03a 0.44±0.02b 0.44±0.03b
.32±0.02b 0.32±0.02b 0.39±0.03c
.50±0.05b 1.46±0.08b 1.26±0.10c
.98±0.08a 2.34±0.08b 2.24±0.07b
TN = Trained+nandrolone. Wet LV weight = Wet left ventricle weight; LVMe = Left
BW = Left ventricle mass corrected by body weight; RWT = Relative wall thickness;
FS = Fractional shortening; E-wave = Early transmitral ﬂow velocity; A-wave = Late
city; IVRTcor = Isovolumic relaxation time corrected by RR interval. Different letters
ls/group.
634 A.P. Tanno et al. / Life Sciences 89 (2011) 631–637Left ventricular collagen content
Nandrolone treatment increased left ventricular collagen content,
in both non-trained and trained groups, compared with respective
non-trained and trained vehicle-treated groups (Fig. 1; pb0.05).
Resistance training associated with nandrolone also induced an
increase in collagen content in comparison with nandrolone non-
trained and vehicle trained animals (Fig. 1; pb0.05).0
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Fig. 1. Left ventricular collagen content, evaluated by polarization microscopy, in rats
submitted to resistance training and treatment with nandrolone or vehicle. Different
letters indicate statistically different groups (Two-way ANOVA+Tukey test; pb0.05).
N=5 animals/group. Data are reported as means±SEM.
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Fig. 2.Molecular markers of pathological left ventricle hypertrophy. Rats were either submit
ribonucleic acid (mRNA) levels: (A) α-MHC (alpha-myosin heavy chain); (B) β-MHC (bet
Peptide). N=9–10 animals/group. Different letters indicate statistically different groups (TCardiac hypertrophy markers
Fig. 2 shows the effects of resistance training and treatment with
nandroloneon the geneexpressionofmolecularmarkers of pathological
cardiac hypertrophy. Nandrolone signiﬁcantly reduced the expression
of α-MHC mRNA in the left ventricle of the NTN and TN groups, in
comparison with the respective NTV and TV groups (Fig. 2A; pb0.05),
with no change induced by resistance training (Fig. 2A; pN0.05).
Resistance training signiﬁcantly reduced the expression of β-MHC
mRNA in the left ventricle of the TV and TN groups, when compared
with the NTV and NTN groups, respectively (Fig. 2B; pb0.05).
Nandrolone promoted an increase of 32% in the expression of
β-MHC in the NTN group in comparison with the NTV control group
(Fig. 2B). Although this percentage was not statistically signiﬁcant, it
showed a tendency to promote the up-regulation of β-MHC during
cardiac hypertrophy produced by nandrolone (p=0.056). Resistance
training per se promoted a 60% reduction in β-MHC expression in the
TV group when compared with the control group NTV (Fig. 2B;
pb0.05), and resistance training associated with nandrolone (TN
group) promoted a reduction of only 23% in β-MHC expression when
compared with the control group NTV (Fig. 2B; pb0.05). These results
also indicated that nandrolone tended to impair the effect of the
resistance training by promoting the down-regulation of β-MHC
(Fig. 2B; p=0.056).
Skeletal α-actin gene expression was signiﬁcantly increased only
in the TN group in comparison with all groups (Fig. 2C; pb0.05).0
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ted to resistance training, or not, and treatment with Nandrolone or Vehicle. Messenger
a-myosin heavy chain); (C) α-SkA (Skeletal alpha-actin); (D) ANP (Atrial Natriuretic
wo-way ANOVA+Tukey test; pb0.05). Data are reported as means±SEM.
635A.P. Tanno et al. / Life Sciences 89 (2011) 631–637Atrial Natriuretic Peptide gene expression was also signiﬁcantly
increased only in the TN group in comparison with all groups (Fig. 2D;
pb0.05).
Discussion
The key ﬁndings of the present study were that resistance training
and nandrolone treatment induced left ventricular hypertrophy
associated with changes in left ventricle geometry, impaired systolic
and diastolic function, and stimulated the re-expression of molecular
markers of pathological cardiac hypertrophy, evidencing the maleﬁc
impact of the association between nandrolone and resistance training
on the cardiovascular system.
The effectiveness of supra-physiological nandrolone doses admin-
istered by intramuscular injections was conﬁrmed by the signiﬁcant
decrease in plasma total testosterone levels in trained or non-trained
rats of the nandrolone-treated groups, when compared with the
respective vehicle-treated groups. This result is in agreement with
those showing that nandrolone treatment results in a decrease in
plasma testosterone (Trifunovic et al., 1995; Castor et al., 2009), and
indicates that a supra-physiological dose of the anabolic androgenic
steroids (AAS) was administered, and that the hypothalamic-
pituitary-gonadal axis was depressed by exogenous AAS (McGinnis,
2004; Castor et al., 2009).
Concentric left ventricular hypertrophy was evidenced by the
increase in both the left ventricle mass/body weight ratio and relative
wall thickness index in the TV, TN, and NTN groups. It is important to
emphasize that these effects were found to be pronounced in the TN
group.
It is well known that inappropriate left ventricular mass plays a
negative prognostic role in the development and progression of
cardiovascular abnormalities (Devereux et al., 1986; Collins et al.,
2001). Therefore, to assess the inﬂuence of concentric hypertrophy on
myocardial performance, systolic and diastolic functions were
evaluated using Doppler echocardiography.
The echocardiographic results showed that nandrolone by itself or
combined with resistance training, induced pathological concentric
hypertrophy, evidenced by a decrease in the cardiac output index, and
by increased isovolumic relaxation time in both trained andnon-trained
groups, when compared with the respective vehicle-treated groups.
This is a maleﬁc adaptation that may reduce the blood supply to organs
and muscles. In addition, nandrolone depressed left ventricle diastolic
function, decreasing the contribution to left ventricle passive ﬁlling and
increasing active ﬁlling, resulting in a lower E/A ratio, which was
paralleled by an increase in ventricular collagen content.
Thedecrease in E/A ratio in the TVgroup in comparisonwith theNTV
group was not paralleled by a change in the left ventricular collagen
content or isovolumic relaxation time in this group. Similar ﬁndings
were obtained in humans by Karhunen et al. (1988), who observed that
supra-physiological doses of nandrolone induced cardiac hypertrophy
and depressedmyocardial contractility. Urhausen et al. (1989) reported
that AAS in highly trained bodybuilders induced an increase in left
ventricular isovolumic relaxation time, and De Piccoli et al. (1991)
showed that AAS abuse is associated with pathological left ventricle
hypertrophy and altered diastolic ﬁlling. The discrepancies between the
results (Hartgens et al., 2003) obtained in some studies conducted in
humans could be attributed to the duration and/or the intensity of
training programs and AAS abuse patterns, and to the difﬁculty of
ﬁnding athletes, who will admit to having taken AAS and are willing to
participate in scientiﬁc investigations (Kuhn, 2002).
According to D'Andrea et al. (2002), the dynamics of left ventricle
passive ﬁlling is inﬂuenced by the time course of active relaxation and
the passive deformation properties of the myocardium, including the
thickness of the wall and its composition, particularly collagen
deposition. In the present study, it was observed that nandrolone
treatment, whether associated with resistance training or not,induced an increase in myocardial collagen content, and consequently
pathological left ventricle hypertrophy. Thus, the left ventricular
dysfunction observed is related to the structural remodeling of the
myocardium, and particularly to the development of myocardial
ﬁbrosis. It is important to mention that other myocardial structural
alterations, such as destroyed mitochondria, aberrant myoﬁbrils, and
necrotic cells in the myocardiummay also account for the dysfunction
(Melchert et al., 1992).
Exercise is known to be a potent cardiac hypertrophic stimulus, but
themagnitude and pattern of left ventricular hypertrophy is dependent
on the nature, duration, and intensity of exercise (Pluim et al., 2000;
Haykowsky et al., 2002). In the heart, there are different morphological
adaptations to resistance and aerobic training. Aerobically trained
athletes mainly develop increased left ventricular chamber size and
mass, while resistance trained athletes develop predominantly in-
creased left ventricular wall thickness without a signiﬁcant left
ventricular chamber enlargement (Suman et al., 2000; D'Andrea et al.,
2006). In both cases left ventricular hypertrophy is called “athlete's
heart”. This physiological adaptation helps themyocardium support the
increased demands of exercise while maintaining or enhancing normal
function (Iemitsu et al., 2001) and is not related to collagen
accumulation in the extracellular matrix (Thomas et al., 2000). In the
present study, the resistance training per se promoted the cardiac
hypertrophy, but without an increase in myocardial collagen content.
However, resistance training associated with nandrolone promoted
cardiac hypertrophy associated with increased myocardial collagen
content, and systolic anddiastolic dysfunction, conﬁguring apathological
left ventricle hypertrophy. Therefore the interaction between nandro-
lone and resistance training seems to have additive or even synergistic
effects on myocardial growth contributing to functional derangements.
Changes in cardiac physiology and structure, such as those observed
in the present study, induced by the administration of supra-
physiological doses of nandrolone, either associated with resistance
training, or not, could be involved inhigher risk of death (for example, in
powerlifters who are AAS users) (Thompson et al., 1992). Although the
association between AAS and exercise may change exercise-induced
physiological cardiac hypertrophy intopathophysiological hypertrophy,
the physiological mechanisms of this change are still poorly understood
(Riezzo et al., 2011a).
Riezzo et al. (2011a) reported increased heart weight, and cardiac
hypertrophy in trained mice treated with high doses of nandrolone,
and attributed this effect to an enhanced protein synthesis in response
to the nandrolone administration. It has been also suggested that
β-adrenoceptor-mediated mechanisms are involved in the develop-
ment of cardiac hypertrophy (Hannan et al., 2003; Sethi et al., 2007;
Riezzo et al., 2011b), depending on the type and stage of hypertrophy
(Sethi et al., 2007). At the early stage of hypertrophy, unaltered (Sethi et
al., 2007) and increasedβ1-adrenoceptor density has been observed due
to pressure overload, which in turn induces concentric cardiac
hypertrophy (Karliner et al., 1980; Ganguly et al., 1989). In addition
volume overload that is known to induce excentric cardiac hypertrophy,
increased β1-adrenoceptor density (Sethi et al., 2007). On the other
hand, in the late stage of both types of hypertrophy, theβ1-adrenoceptor
density is attenuated (Sethi et al., 2007; Riezzo et al., 2011b).
In addition to the possible β-adrenoceptor-mediated mechanisms
mentioned above, the cardiac hypertrophy can also lead to changes in
contractile protein gene expression, altering the distribution ofα- and
β-MHC (Myosin Heavy Chain) isoforms, both in physiological and
especially in pathological conditions, in which we can observe re-
expression of skeletal α-actin, and the genes of non-contractile
proteins such as Atrial Natriuretic Peptide (ANP) (Oliveira and
Krieger, 2005; Soci et al., 2011), whose expression is rarely increased
in normal adult rats. In the present study, resistance training
promoted cardiac hypertrophy in the TV and TN groups. In both
groups, training was capable of reducing β-MHC gene expression,
which is predominant in the left ventricle of rats in fetal life, without
636 A.P. Tanno et al. / Life Sciences 89 (2011) 631–637changes in α-MHC gene expression, predominantly expressed in the
adult rats (Mahdavi et al., 1984).
It is important to point out that the resistance training protocol used
in the present study is efﬁcient in promoting the down-regulation of
β-MHC mRNA expression, but is not efﬁcient in promoting the up-
regulation of α-MHC mRNA. These results seem to contradict the
condition that occurs in pathological cardiac hypertrophy, which is an
up-regulation of β-MHCmRNA. In addition, the resistance training was
not able to promote signiﬁcant re-expression of skeletalα-actin, and/or
ANP genes. Thus, the molecular analysis of this study shows that the
cardiac hypertrophy resulting from resistance training alone is not of a
pathological nature.
The nandrolone by itself produced cardiac hypertrophy. In fact, a
previous study reported the presence of androgen receptors in cardiac
cells in both humans and animals (Marsh et al., 1998).Moreover, there is
evidenceof thepresenceof endogenouspathwaysof androgen actions in
the development of cardiac hypertrophy, and a higher expression of
androgen receptors in hypertrophied hearts in humans and rats (Liu et
al., 2003; Rocha et al., 2007). AAS appear to act directly on the heart
through the action of nuclear receptors, increasing the expression of
mRNAand stimulating cardiac protein synthesis, resulting inmyocardial
hypertrophy (Melchert and Welder, 1995).
Generally, pathological left ventricular hypertrophy is character-
ized by an increase in myocyte size, and gene reprogramming, such as
enhanced expression of β-MHC, skeletal α-actin, and/or ANP genes
(Kim and Iwao, 2000). In the present study, nandrolone showed a
trend towards promoting the up-regulation of β-MHC in the NTN
group when compared with the control group NTV, and simulta-
neously it was capable of minimizing the beneﬁcial effect of resistance
training. The ventricular β-MHC isoform has lower ATPase activity,
therefore, the increase in proportion of this myocardial isoform is
associated with slower shortening velocity of the cardiac ﬁbers, and
pathological cardiac hypertrophy (Kim and Iwao, 2000).
If the relative increase in the proportion of α-MHC isoform in
comparison with β-MHC is indicative of high ATPase activity, which is
associated with improvement in systolic function (Scheinowitz et al.,
2003), an increase in the proportion of β-MHC could obviously
indicate the opposite effect.
Nandrolone treatment associatedwith resistance trainingpotentiated
the cardiac hypertrophy, whichmay result from the high intensity of the
training protocol used in this study.
The association of nandrolone plus training promoted signiﬁcant re-
expression of skeletal α-actin and ANP genes in the TN group when
compared with all the other groups. The signiﬁcant re-expression of
ANP, associated with other markers, such as skeletal α-actin, can be
considered one among several criteria that indicate pathological cardiac
hypertrophy (Klein et al., 1995; Baraunaet al., 2008). These results show
thatwhennandrolone treatment is associatedwith resistance training it
promotes not only an increase inmyocyte size (quantitative change)but
also signiﬁcant myocyte gene reprogramming (qualitative change).
Conclusions
Considering the increased ventricle collagen content, diastolic and
systolic function impairment, and the re-expression of the fetal genes
observed in the left ventricle of rats, we concluded that nandrolone by
itself or associated with high-intensity resistance training induces
pathological cardiac hypertrophy. Nandrolone per se increased collagen
in the left ventricle, decreased the cardiac output index, andwas capable
of damaging thebeneﬁcial effects of resistance trainingonventricularβ-
MHC mRNA expression. The association of resistance training with
nandrolone induced the re-expression of Atrial Natriuretic Peptide and
skeletal α-actin, which was parallel to diastolic and systolic function
impairment. Thus, these results may contribute to understanding the
underlying mechanisms involved in the pathological cardiac hypertro-
phy promoted by AAS abuse, and represent a potential tool forunderstanding the sudden death of strength trained athletes who are
AAS users.
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